Adicet Bio, Inc.
ACET$1.13B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON152 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 15, 2026
13wMarket Overview
Stock performance and key metrics
ACET News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ADI-270 | Phase 2 | Clear Cell Renal Cell Carcinoma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply